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Bile acids (BAs) are molecules derived from cholesterol that are involved in dietary fat
absorption. New evidence supports an additional role for BAs as regulators of brain
function. Sterols such as cholesterol interact with monoamine transporters, including the
dopamine (DA) transporter (DAT) which plays a key role in DA neurotransmission and
reward. This study explores the interactions of the BA, obeticholic acid (OCA), with DAT
and characterizes the regulation of DAT activity via both electrophysiology and molecular
modeling. We expressed murine DAT (mDAT) in Xenopus laevis oocytes and confirmed its
functionality. Next, we showed that OCA promotes a DAT-mediated inward current that is
Na+-dependent and not regulated by intracellular calcium. The current induced by OCA
was transient in nature, returning to baseline in the continued presence of the BA. OCA
also transiently blocked the DAT-mediated Li+-leak current, a feature that parallels DA
action and indicates direct binding to the transporter in the absence of Na+. Interestingly,
OCA did not alter DA affinity nor the ability of DA to promote a DAT-mediated inward
current, suggesting that the interaction of OCA with the transporter is non-competitive,
regarding DA. Docking simulations performed for investigating the molecular mechanism
of OCA action on DAT activity revealed two potential binding sites. First, in the absence of
DA, OCA binds DAT through interactions with D421, a residue normally involved in
coordinating the binding of the Na+ ion to the Na2 binding site (Borre et al., J. Biol.
Chem., 2014, 289, 25764–25773; Cheng and Bahar, Structure, 2015, 23, 2171–2181).
Furthermore, we uncover a separate binding site for OCA on DAT, of equal potential
functional impact, that is coordinated by the DAT residues R445 and D436. Binding to that
site may stabilize the inward-facing (IF) open state by preventing the re-formation of the IF-
gating salt bridges, R60-D436 and R445-E428, that are required for DA transport. This
study suggests that BAs may represent novel pharmacological tools to regulate DAT
function, and possibly, associated behaviors.
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INTRODUCTION
Bile acids (BAs) are amphipathic molecules derived from
cholesterol that are primarily synthesized in the liver and stored
in the gallbladder. Upon food consumption and transit, BAs are
released into the duodenum (Mertens et al., 2017) where their main
physiological role is solubilization and absorption of dietary fat.
Administration of BAs has been developed into successful therapies
for the treatment of liver and gallbladder pathologies, such as non-
alcoholic steatohepatitis and cholelithiasis (Cruz-Ramon et al.,
2017; Li and Chiang, 2020). When administered orally, they
exhibit favorable bioavailability. They are readily absorbed
through the portal vasculature and distributed throughout the
body (Kiriyama and Nochi, 2019; Fiorucci et al., 2021).
Receptors for BAs are present throughout the brain
(Maruyama et al., 2002; Kawamata et al., 2003; Keitel et al.,
2010; Huang et al., 2015; Perino et al., 2021) and evidence exists
for their synthesis directly in the CNS (McMillin and DeMorrow,
2016; Mertens et al., 2017; Kiriyama and Nochi, 2019). This raises
the possibility of physiologic roles for BAs other than acting as an
adjuvant in fat absorption, such as regulators of CNS activity.
Consistent with this idea, freely circulating BAs have been
implicated in the modulation of CNS proteins such as NMDA,
GABAA and M3 muscarinic receptors (Raufman et al., 2002;
Schubring et al., 2012), the activation of neuronal ion channels
(Wiemuth et al., 2014; Kiriyama and Nochi, 2019) and
stimulation of the release of neuroactive peptides such as
GLP-1 (Flynn et al., 2019; Chaudhari et al., 2021; Fiorucci
et al., 2021). BAs pass the blood-brain barrier (BBB) through
passive diffusion, as well as through active membrane
transporters, and BA levels in the brain have been correlated
to plasma levels (Mano et al., 2004; Higashi et al., 2017; Reddy
et al., 2018; Kiriyama and Nochi, 2019). The number of studies
proposing BAs as a treatment for brain disorders are steadily
increasing (Bhargava et al., 2020; Wu et al., 2020; Huang et al.,
2021; Jin et al., 2021; Zangerolamo et al., 2021) but understanding
of their mechanisms of action is still limited.
BA concentrations vary in the body following a circadian
rhythm and are highly influenced by the fasting vs fed state
(Fiorucci et al., 2021; Perino et al., 2021). Changes in circulating
BAs are also promoted by pathological alterations in liver
functionality and metabolism (Fiorucci et al., 2021). Multiple
types of bariatric surgery increase circulating BAs and, in mice,
cause loss of preference for dietary fat (Scholtz et al., 2014;
Bensalem et al., 2020) and, interestingly, cocaine (Reddy et al.,
2018). Further, feeding BAs to mice recapitulated the effects of
bariatric surgery on cocaine preference, strongly supporting their
ability to modulate reward circuitries in the CNS as well as
dopamine (DA) neurotransmission (Reddy et al., 2018).
Understanding the molecular determinants of these actions
could facilitate BA-based therapies for drug use disorders as
well as identify potential new therapeutic targets.
BAs are directly derived from cholesterol and retain a high degree
of structural similarity with the parent molecule but differ by the
presence of various R groups, many of which are charged, added to
the A, B, and C rings as well as the hydrocarbon tail. Resulting BAs
are less lipophilic and more soluble in aqueous solutions relative to
cholesterol (Russell, 2003). The importance of cholesterol in
monoamine transporter (MAT) function and membrane
localization is well documented (Foster et al., 2008; Chang and
Rosenthal, 2012). Cholesterol depletion modulates both MAT
expression (Butchbach et al., 2004; Magnani et al., 2004; Foster
et al., 2008) and activity (Magnani et al., 2004; Adkins et al., 2007;
Foster et al., 2008; Hong and Amara, 2010). There are indications of
direct interactions between cholesterol and MATs such as the DA
transporter (DAT) and human serotonin transporter (hSERT)
(Cremona et al., 2011; Jones et al., 2012; Penmatsa et al., 2013;
Wang et al., 2015; Coleman et al., 2016; Zeppelin et al., 2018)
whereas no information is available on interactions occurring
between BAs and MATs. Thus, investigations of the functional
relevance of interactions between cholesterol-like molecules and
MATs are needed to further define the central regulatory role of
these sterols. This study demonstrates the ability of BAs to alter DAT
activity and identifies putative binding sites that may underlie the
structural changes driving these alterations.
MATERIALS AND METHODS
Solutions
Composition of buffered solution (ND96) (in mM): NaCl 96, KCl
2, CaCl2 1.8, MgCl2 1, HEPES 5, pH 7.6. Composition of NDE
solution: ND96 plus 2.5 mM pyruvate and 50 μg/ml Gentamycin
sulphate. Composition of external control buffer (ND98) (in
mM): NaCl 98, MgCl2 1, and CaCl2 1.8 with or without 0.01%
DMSO. In tetramethylammonium (TMA)-chloride “zero
sodium” buffer (TMA98), equimolar TMACl replaces NaCl. In
Li+ buffer, equimolar LiCl replaces NaCl. The final pH was
adjusted using respective hydroxides (NaOH or TMAOH or
LiOH) to 7.6 for all external solutions. Substrates used were
Dopamine (DA) (Calbiochem - Sigma, Milan, Italy), Lithocholic
acid (LCA) (Sigma), and Obeticholic acid (OCA) (Adipogen,
Switzerland). LCA or OCA powder was dissolved in DMSO at
50 mM and 100 mM, respectively.
Oocytes Collection and Preparation
Oocytes were obtained from adult Xenopus laevis females.
Animals were anaesthetised in 0.1% (w/v) MS222 (tricaine
methanesulfonate; Sigma) solution in tap water. Abdomens
were sterilized with antiseptic agent (Povidone-iodine 0.8%),
laparotomy was performed, and portions of the ovary were
collected. The oocytes were treated with 0.5 mg/ml collagenase
(Sigma Type IA) in ND96 calcium-free for at least 30 min at 18°C.
Healthy and fully-grown oocytes were selected and stored at 18°C
in NDE solution (Bossi et al., 2007). The day after the removal, the
oocytes were injected with cRNA using a manual microinjection
system (Drummond Scientific Company, Broomall, PA). Injected
concentrations were 12.5 ng/50 nl for the mouse dopamine
transporter (mDAT), 2 ng/50 nl for human Takeda G protein-
coupled receptor (hTGR5).
cRNA Preparation
mDAT cDNA in pcDNA3.1 was kindly gifted from Prof. Dr.
Harald Sitte of Medical University of Vienna. The cDNA mDAT
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was amplified with forward and reverse primers containing SmaI
and EcoRI restriction sites, respectively (5′-GACTCCCGGGACC
CATGAGTAAAAGCAAATG-3′; 5′-GCATGAATTCTTACAG
CAACAGCCAATGGCGC-3′). The amplified coding sequence
was then subcloned into the pGHJ vector after double digestion
with SmaI e EcoRI restriction enzymes (Promega). hTGR5 gene
was in pCMV6-Entry (GPBAR1 Human cDNA ORF Clone,
NM_001077191; Origene Technologies, Inc., Rockville, MD,
United States). The two plasmids were linearized with SalI
(mDAT) and with NdeI (hTGR5), in vitro capped, and
transcribed using T7 RNA polymerase. Enzymes were supplied
by Promega Italia. The oocytes were incubated at 18°C for
2–3 days prior to electrophysiological experiments. The
experimental protocol was approved locally by the Committee
of the “Organismo Preposto al Benessere degli Animali” of the
University of Insubria (OPBA-permit #02_15) and nationally by
Ministero della Salute (permit nr. 1011/2015).
Electrophysiology
Electrophysiological studies were performed using the Two-
Electrode Voltage Clamp (TEVC) technique (Oocyte Clamp OC-
725; Warner Instruments, Hamden, CT, United States). Controlling
software was WinWCP version 4.4.6 (J. Dempster, University of
Strathclyde, United Kingdom) or Clampex (Molecular Devices,
Sunnyvale, CA, United States, www.moleculardevices.com).
Borosilicate microelectrodes, with a tip resistance of 0.5–4MΩ,
were filled with 3M KCl. Bath electrodes were connected to the
experimental oocyte chamber via agar bridges (3% agar in 3MKCl).
The holding potential was kept at −60mV for all the experiments.
The minimal concentration of OCA inducing inward current was
evaluated by applying concentration of OCA from 1 pM to 100 µM.
Each dose was tested on one single oocyte, exposed before to 30 µM
DA. The current in the presence of OCA is the maximal current
measured at the peak. For the I/V relationships, a step protocol from
−160mV to +40mV with 20mV of increment was applied for
100ms. Themean of the transport-associated currents plotted in the
scatter diagrams and in the I/V relationships were determined by
subtracting the current recorded in the ND98 buffer from the
current recorded in the presence of DA or OCA. In experiments
using TMA, subtraction was performed with the current in TMA98
buffer. To chelate intracellular calcium, oocytes were injected with
50 nl of an intracellular solution containing 13mM EGTA 30min
prior to electrophysiological recording. Intracellular solution had the
following composition (inmM): KCl 130, NaCl 4,MgCl2 1.6,HEPES
10, glucose 5, pH 7.6. The dose-response experiments in Figure 4
were performed exposing the same oocytes first to all the
concentrations of DA alone, then to the same concentrations
plus 10 µM OCA. Data analysis was performed using Clampfit
10.2 software (Molecular Devices, Sunnyvale, CA, United States,
www.moleculardevices.com); OriginPro 8.0 (OriginLab Corp.,
Northampton, MA, United States, www.originlab.com) and
GraphPad Prism (www.graphpad.com/scientific-software/prism)
were used for statistical analysis and figure preparation.
Structural Models for mDAT and hDAT
The mDAT (residues R56 to N596; UniProt ID O55192) in the
outward-facing open (OFo), occluded, and inward-facing open (IFo)
states were generated using SWISS-MODEL (Waterhouse et al.,
2018) based on the structures resolved for OFo Drosophila DAT
(dDAT) (PDB: 4M48) (Penmatsa et al., 2013), occluded hSERT
(PDB: 6DZV) and IFo hSERT (PDB: 6DZZ) (Coleman et al., 2019).
Homology models for hDAT in these conformational states were
taken from previous work (Cheng et al., 2018; Aggarwal et al., 2021).
Docking Simulations
OCA 3D structures were downloaded from the ZINC database
(Irwin and Shoichet, 2005) (ZINC14164617) and DrugBank
(Wishart et al., 2006) (DB05990). The net charge of OCA is
indicated to be −1 in the ZINC database, and zero in
DrugBank. Docking simulations were performed using both
electronic states, designated as OCA(−) and OCA(n) for the
negatively-charged and neutral OCAs, respectively. The binding
sites and binding poses on both mDAT and hDAT, in different
conformational states, were assessed using docking simulation
software AutoDock4 (Morris et al., 2009) and AutoDock Vina
(Trott and Olson, 2010). Autodock Vina simulations were carried
out using a grid with dimensions set to 84 × 58 × 86 Å3 and center
at (−1.22, 1.16, −6.26 Å) for each conformer and each transporter.
This grid box encapsulated the entire structure of the transporter.
The number of runs (exhaustiveness parameter in Autodock Vina)
was set to 50 and the algorithm returned 20 binding modes of
interest for each conformer. AutoDock4 simulations were
performed following previously published protocols (Cheng
et al., 2015; Aggarwal et al., 2021). Briefly, Lamarckian genetic
algorithmwith default parameters was employed with the maximal
number of energy evaluations set to 2.5 × 107. The binding energy
was estimated from the weighted average of multiple binding poses
at a given site observed in 100 independent runs.
RESULTS
OCA Induces a DAT-Dependent, Transient
Inward Current
To begin to investigate the regulatory effects of OCA on DAT
electrical activity, Xenopus laevis oocytes were tested by two-
electrode voltage clamp (TEVC) (Figure 1A). Perfusion of DA
onto the oocytes expressing the mouse DAT (mDAT) generated
an inward current (−12.5 nA ± 0.63) (Figures 1B,C, left),
confirming the expression and functionality of the transporter.
On the same oocytes, following DA washout, perfusion of 10 µM
OCA also generated an inward transport current (−8.28 nA ±
0.6). This membrane conductance exhibited a lower amplitude
and inactivated rapidly (Figures 1B,C, left). The OCA-induced
transient inward current was also elicited when OCA was
perfused prior to DA exposure (data not shown).
Next, we set out to understand whether the OCA current was
mediated by endogenous targets of OCA. One of the main targets
of OCA, the G-Protein Coupled Receptor TGR5, is shown to be
only minimally expressed in Xenopus laevis oocytes as reported in
the platformXenbase (Yanai et al., 2011; Session et al., 2016; James-
Zorn et al., 2018). As shown in Figure 1B, no response from the
perfusion of OCA was obtained in control oocytes (i.e., not
expressing any heterologous protein). Thus, an activation of
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endogenous targets seems unlikely. As previously reported in
literature, oocytes can express functional human TGR5
(hTGR5) (Lieu et al., 2014) as demonstrated by modulation of
various membrane proteins upon TGR5 activation. We expressed
hTGR5 in oocytes and measured OCA-induced currents. No
currents were observed in hTGR5 expressing oocytes upon
OCA perfusion (Figure 1B, right and Figure 1D). Next, we
tested oocytes co-expressing mDAT and hTGR5. The currents
FIGURE 1 | OCA generates an electrical current through the DAT. (A) Schematic representation of oocyte collection, cRNA synthesis and injection, and TEVC
technique. (B) Representative traces of currents recorded by TEVC (Vh  −60 mV) from oocytes expressing mDAT, without or with hTGR5, uninjected, or expressing
hTGR5 alone. The oocytes were perfused with 30 µM DA or 10 µM OCA. (C) Mean of the maximal DA-associated and OCA-induced currents (I nA ± SE of 14–47
oocytes, 6–11 batches) in oocytes expressing mDAT (C, left) or mDAT plus TGR5 (C, right). (D) Mean of the maximal OCA-induced currents in oocytes
expressing the proteins indicated; one-way ANOVA F(2,74)  36.13, p < 0.0001 followed by Tukey’s multiple comparison test (mDAT vsmDAT-hTGR5 p  0.566, mDAT
vs hTGR5 p < 0.0001). (E) Representative traces of currents recorded by TEVC (Vh  −60 mV) from oocytes tested with DA (30 µM) and OCA at the indicated
concentrations. The current of each trace was normalized to the mean current of dopamine to reduce the variability between batches. (F) I/V relationships of DA (30 µM)
and OCA (10 µM)-induced currents.
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recorded from these cells in response to DA (−12.88 nA ± 0.9) and
OCA (−9.37 nA ± 0.82) alone (Figure 1B, center and Figure 1C,
right) were comparable to the ones recorded in oocytes expressing
mDAT alone (Figure 1D). This data suggests that the inward
current induced by OCA is directly mediated by mDAT.
Dose-response experiments determined that 10 µM OCA was a
saturating concentration. The EC50 was not calculated for this
interaction because the current amplitude was consistent in
response to over an eight order of magnitude range of OCA
concentrations, as low as 1 pM and as high as 100 µM OCA
(Figure 1E). The concentration of 10 µM was chosen
throughout this study because it approximates the concentration
of OCA in the plasma after oral administration and is sufficient to
activate physiological targets of OCA in vitro (Roda et al., 2014).
To better characterize the OCA-induced current, we performed
a voltage step protocol and obtained I/V curves for the transporter
with DA and OCA (Figure 1F). As expected, DA-induced currents
increased at negative potential without reverting. At positive
voltages, the I/V curve for DA shows the distinctive inverted U
shape, previously reported by Sonders and coworkers (Sonders
et al., 1997), which is a hallmark of blockage of the tonic Na+-leak
current. OCA displays a similar curve shape. However, it shows an
increase in conductance at negative potentials and a lack of
inversion at positive potentials (Figure 1F). These characteristics
point towards OCA opening a conductance in mDAT.
OCA Modulates the DAT Li+-Leak Current
Several members of the solute carrier 6 (SLC6) family of
transporters exhibit basal leak currents (Lester et al., 1994; Bossi
et al., 1999; Andrini et al., 2008) that are augmented in the presence
of Li+ ions. The Li+-leak current can be utilized to highlight the
effect of molecules that interact with transporters and modify their
electrical activity in the absence of Na+. DAT shows a significant
Li+-leak current that is partially blocked uponDA perfusion (Giros
et al., 1992; Sonders et al., 1997). Therefore, we used Li+ to
investigate whether OCA, similarly to DA, binds mDAT in the
absence of Na+. Oocytes were perfused first either with DA orOCA
in Na+ bathing buffer (Figures 2A,B). Switching to Li+ bathing
buffer induced a large inward current (−92.41 nA ± 7.45) (Figures
2A,B). As expected, the addition of DA to the Li+ buffer partially
blocked the Li+-leak current (Figures 2A,B). This inhibition
occurred in two phases; a rapid transient component (current at
the peak: −25.72 nA ± 4.07) followed by a steady-state condition
(−38.97 nA ± 5.11). After DA removal, the Li+-leak current
returned to initial values (Figure 2A). Interestingly, perfusion of
OCA also partially blocked the Li+-leak current (Figures 2A,B). As
with DA, this inhibition displayed two phases; a transient rapid
component (current at the peak: −66.86 nA ± 6.13) and a steady-
state component (−82.42 nA ± 7.69). Inhibition of the Li+-leak
current is a strong indication of direct binding of OCA to the
transporter in the absence of Na+.
mDAT-Mediated OCA Current Is Na+
Dependent
In addition to a coupled mechanism, Na+ also permeates through
DAT in the absence of DA. This generates a leak current that can
be uncovered when Na+ is substituted by non-permeant cations
such as choline or TMA+ (Sonders et al., 1997). To better
understand the effect of OCA on membrane conductance and
the relevance of Na+ in the OCA-induced inward current,
experiments were repeated with TMA+ as the cation
substituting for Na+ in the bathing buffer. TMA+ blocked the
Na+-leak current (15.12 nA ± 1.71) (Figures 2C,D). As expected,
in the presence of TMA+, DA elicited only a fast-transient inward
current (−1.98 nA ± 0.37), confirming that Na+ is necessary for
mDAT-mediated DA currents. OCA behaved similarly to DA:
the inward current was still present but greatly reduced in
amplitude (−1.83 nA ± 0.38) (Figures 2C,D). The substitution
of TMA+ for Na+ greatly affected the amplitude of the OCA-
induced currents, pointing to a major role for the permeation of
Na+ ions in causing the OCA-induced currents recorded in
physiological solution.
OCA-Induced Current Is Not Due to an
Increase in Intracellular (IC) Calcium
OCA has been shown to induce IC Ca2+ fluctuations (Hao et al.,
2017). Thus, it is possible that the OCA-induced inward current
could be generated by the activation of chloride conductance due
to an increase in IC Ca2+ concentrations. To investigate this
possibility, experiments were conducted in oocytes expressing
mDAT and injected with the Ca2+-chelating agent EGTA
(Figure 3A). The presence of EGTA did not alter mDAT-
mediated currents elicited by DA or OCA (Compare
Figure 3B with Figures 1B,C). Maximal OCA-induced inward
currents were also not altered by the presence or absence of
EGTA (Figure 3C). Together, these data strongly suggest that IC
Ca2+ does not regulate OCA-induced currents and further suggest
that effects of OCA are mediated by direct interaction
with mDAT.
OCA Does Not Alter Either DAT-Mediated
DA Currents or DA Affinity
Data thus far indicate that OCA interacts directly with mDAT in
the absence of DA. We next investigated whether OCA regulates
DAT-mediated DA-induced currents. Currents generated from
increasing concentrations of DA were unaltered by the presence
of 10 µM OCA even at low DA concentration (Figures 4A,B).
Mean of maximal currents were fitted to a Hill equation
(Figure 4C) and the results reported in Figure 4D. These data
indicated that the presence of OCA does not significantly affect
either the affinity or the maximal transport currents.
Lithocholic Acid Induces DAT-Mediated
Currents
To determine whether the OCA-induced mDAT-mediated
current is specific to OCA, or is a common phenotype
induced by bile acids, we investigated the effect of the
natural bile acid, lithocholic acid (LCA). OCA and LCA
share the same sterol-based structure with different R groups
at positions 5 and 6 of the B ring (Figure 5A). Specifically, ethyl
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and hydroxyl groups present in OCA are substituted by
hydrogen in LCA. Similar to OCA, perfusion of 10 µM LCA
onto mDAT-expressing oocytes induced a transient inward
current (−10.25 nA ± 2.06) (Figures 5B,C). Direct comparison
of OCA and LCA revealed no significant differences in their
ability to induce DAT-mediated currents (Figure 5C). These
data suggest that the ability of OCA to promote DAT-mediated
currents is shared by another BA.
The Binding Pose of OCA(n) Suggests That
It Binds to DAT in a Non-Competitive
Fashion, That Allows Simultaneous Binding
of DA
To identify potential sites for binding of OCA onto mDAT and
hDAT, docking simulations were performed, using AutoDock4
(Morris et al., 2009) and AutoDock Vina (Trott and Olson,
2010). To account for alternative protonated and deprotonated
states of OCA, both the neutral (OCA(n)) and negatively-
charged (OCA(−)) forms (Figure 6D) were used in the
simulations. Computations were performed for the outward-
facing open (OFo), occluded (OCC), and inward-facing open
(IFo) states of both mDAT and hDAT. The computations
revealed that OCA selected similar binding poses, with
comparable binding affinities, for either transporter when the
same conformational state was targeted regardless of the species.
Therefore, representative results for hDAT are presented unless
otherwise stated.
Figure 6A illustrates the top-ranking distinct binding poses
and sites of both OCA forms, observed in docking simulations,
onto hDAT in the OFo and IFo states in the absence of DA. Panel
B shows the comparison to the DA-bound structures resolved for
dDAT (Wang et al., 2015) in the presence of OCA, and panel C to
ibogaine-bound hSERT (Coleman et al., 2019). Notably, in the
case of the OFo conformer, the most favorable binding sites for
both the neutral and negatively charged forms of OCA are within
the extracellular (EC) vestibule but the exact locations are
determined by the protonation state of the ligand. In the
absence of DA, OCA(−) occupies the S2 site proposed to
allosterically modulate transport (Cheng and Bahar, 2019),
whereas OCA(n) binds an extended region spanning between
the primary (S1) and secondary (S2) sites (Figure 6A, top panels).
The binding pose of OCA(−) thus differs from that of the DA
bound to OFo DAT (Figure 6B) where the residue equivalent to
hDAT D79 (D46 in dDAT) plays a major role in coordinating the
binding of the amine group through a salt bridge formation
FIGURE 2 | OCA modulates the mDAT-mediated leak current. (A) Representative current traces recorded with TEVC (Vh  −60 mV) in oocytes expressing mDAT
perfused with 30 µM DA or 10 µM OCA in ND98 or Li98 buffer. (B)Mean of maximal currents under conditions shown in A (I nA ± SE of 6–28 oocytes, 4 batches. One-
way ANOVA F(4,94)  42.29, p < 0.0001 followed by Bonferroni’s multiple comparison test (DA vs OCA p > 0.999, DA vs DA in Li+ p > 0.999, OCA vs OCA in Li+ p 
0.0004, DA in Li+ vs OCA in Li+ p < 0.0001). (C) Representative trace from oocytes expressing mDAT perfused with 30 µM DA or 10 µM OCA in ND98 or TMA98
buffer. (D) Mean of maximal currents under conditions shown in C (I nA ± SE of 6–15 oocytes, 3 batches. One-way ANOVA F(4,51)  86.94, p < 0.0001 followed by
Bonferroni’s multiple comparison test (DA vs OCA p  0.359, DA vs DA in TMA+ p < 0.0001, OCA vs OCA in TMA+ p  0.059, DA in TMA+ vs OCA in TMA+ p > 0.999).
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(Penmatsa et al., 2013;Wang et al., 2015; Cheng and Bahar, 2019).
Notably, when DA is present, the top binding poses of OCA do
not block the binding of substrate DA (Figure 6B, left panel),
such that DA is able to bind in the proximity of OCA. This is
consistent with the non-competitive binding of OCA revealed in
TEVC experiments (Figure 4).
For the IFo conformer, no high affinity binding is observed to
the EC vestibule. For OCA(n), the top binding site is in proximity
to D421 within the IC vestibule (Figure 6A, bottom right panel).
OCA(−) preferentially binds near the IC entrance, in the
proximity to R445, and no high affinity binding is observed
within the vestibule. Notably, docking simulations also
revealed binding instances within the transmembrane region,
including the site known to be occupied by cholesterol near TM1a
(Penmatsa et al., 2013; Cheng and Bahar, 2019), or a site close to
residues R443/H444 (Figure 6A, middle left panel) reported
previously as a PIP2 binding site (Belovich et al., 2019).
However, these sites could potentially be obstructed by lipid
molecules, which are not included in docking simulations, and
hence will not be further elaborated.
Unexpectedly, in the case of the occluded DAT conformer
(Figure 6C), both charged and neutral OCAs (OCA(n/−)) are
predicted to bind to the S1 site, with almost identical affinity, and
the binding pose closely resembles that resolved for ibogaine-
bound hSERT. Of note, the binding pocket in the occluded state
may be much larger than anticipated, with possible involvement
of TM9 (Figure 6C, right panel).
Taken together, these docking simulations suggest that the
binding sites and affinities depend on the net charge carried by
OCA and on the conformational state of the transporter. In the
OFo state, the binding site for OCA(n) closely neighbors, but does
not overlap with, the S1 site resolved for DA (Wang et al., 2015);
whereas, in the absence of DA, the binding site for OCA(−)
overlaps with the broadly-defined S2 site (Figure 6A). In the IFo
state, on the other hand, OCA binds near D421 or R445,
depending on its protonation state. Notably, in the occluded
state of the transporter, OCA appears to select a binding site
similar to that resolved for ibogaine-bound to hSERT (Coleman
et al., 2019) regardless of its charge. However, caution is needed
when interpreting docking-predicted binding sites, especially in
FIGURE 3 | Intracellular calcium does not regulate OCA-induced currents. (A) Schematic representation of the EGTA injection technique. (B) Representative trace
of current recorded by TEVC (Vh  −60 mV) in oocytes expressing mDAT and injected with 13 mM EGTA in intracellular solution 30 min before exposure to 30 µM DA or
10 µMOCA in ND98 buffer (top) and themean of maximal transport-associated and OCA-induced currents (bottom) (I nA ± SE of 6–7 oocytes, 2 batches). (C)Mean of
maximal OCA-induced currents in mDAT oocytes with or without injection of EGTA. Two-tailed Student’s t-test, p  0.476.
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the occluded state. The S1 site suggested in the occluded DAT
conformer may not be accessible to OCA(−) in practice, even
though it forms the pocket with the highest affinity, due to the fact
that OCA(−) does not bind to the S1 site in the OFo conformer.
DISCUSSION
The comprehensive role of BAs in brain physiology is still unclear,
but evidence of their involvement in various brain functions is
continually increasing. BA concentrations in the brain strongly
correlate with their plasma concentrations (Mano et al., 2004;
Higashi et al., 2017). OCA, the main BA considered in this study,
reaches a plasma concentration around 15 µM following
intraduodenal administration in rats (Roda et al., 2014),
comparable to the 10 μM concentrations used in bath
applications for the TEVC studies reported here. Twenty BAs
have been detected in brain lysates and most are present in forms
loosely bound to proteins (Higashi et al., 2017; Kiriyama and
Nochi, 2019). In contrast, cholesterol, which is highly lipophilic,
is only soluble and present in plasma when tightly bound to plasma
proteins (Cortes et al., 2014). As a consequence, regulation of DAT
via cholesterol occurs upon intercalation into the plasma
membrane (Hong and Amara, 2010; Zeppelin et al., 2018).
However, the increased charge present on BAs likely precludes
this mechanism for regulation of MATs via these molecules.
Although our docking simulations revealed, among others,
binding instances of OCA to the site known to be occupied by
cholesterol (Penmatsa et al., 2013; Cheng and Bahar, 2019), this site
is likely obstructed by higher affinity lipid molecules, which are not
included in docking simulations, and hence were not further
elaborated.
These current findings highlight previously undocumented
interactions and impact of BAs on DAT function. Specifically, we
show that this interaction promotes a current that is transient in
nature and is Na+-dependent. OCA is capable of inhibiting, as
observed for DA (Sonders et al., 1997), a DAT-mediated Li+-leak
current suggesting that BAs can interact with DAT even in the
absence of Na+. Furthermore, the OCA-induced current does not
depend upon changes in intracellular calcium levels. In our
interpretation, the presence of a DAT-mediated OCA current
suggests that OCA could induce an occluded conformation of the
transporter. This conformational state could transition to an
outward facing conformer upon binding to substrate, as
suggested by the competition experiments.
As per the nature of the current itself, the data obtained
strongly suggest that the current generated by OCA is a DAT-
mediated, Na+-dependent leak current. In previous in silico
studies of DA-free DAT conformers (Cheng et al., 2018;
Cheng and Bahar, 2019), the EC- and IC-exposed helices were
not as tightly packed as in the occluded DA-bound form. These
conformers occasionally gave rise to simultaneous opening of
both the EC and IC gates such that formation of an intermittent
water channel was detected. Notably, the sodium permeation
pathway (Aguilar et al., 2021) coincides with that of water
channeling (Cheng et al., 2018; Cheng and Bahar, 2019). This
FIGURE 4 | OCA does not alter the DA transport associated current. (A) Representative traces of the current recorded at increasing concentrations of DA in the
absence or presence of 10 µM OCA. (B) Mean currents recorded from the traces in (A). Two-way ANOVA, Treatment F(1,142)  0.51, p  0.476 – DA concentration
F(4,142)  77.76, p < 0.0001 – Interaction F(4,142)  0.24, p  0.915. (C) Data from (A) were fitted to a Hill equation. (D) Imax, K0.5, and Hill coefficient obtained from
fitting the data represented in (B) to the Hill equation.
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path, observed in silico, may also be associated with DAT-
mediated ion fluxes or leak currents (Ingram et al., 2002;
Erreger et al., 2008). Furthermore, Na+ substitution with
TMA+ strongly reduces the ability of OCA to induce this
current. The blocking of the Li+-leak current could be caused
by binding of OCA, in the charged state, to the S2 substrate site,
and its deeper insertion and translocation after protonation that
may induce intramolecular rearrangements similar to DA.
Differences were observed between the effects of OCA and
DA on DAT conductance in terms of steady-state currents.
This may be due to the fact that the release of DA and
simultaneously-bound Na+ restores DAT into a transporter
mode (Borre et al., 2014), whereas the non-substrate OCA
will not facilitate full procession to this state resulting in a
current that is transient. Considering that Li+ leakage in DAT is
dependent on the Na2 site rather than the Na1 site (Borre et al.,
2014), another possibility is that D421 in hDAT coordinates the
binding of the Na+ ion to the Na2 site (Borre et al., 2014; Cheng
and Bahar, 2015). Notably, the present docking simulations also
indicate that D421 may contribute the binding of OCA(n)
(Figure 6A) in the IFo state. The direct binding of OCA to
D421 may also potentially block Li+ permeation. However, we
cannot rule out the possibility that inhibition of the Li+ current
by OCA may reflect a shift of conformational equilibrium
between different functional states along the transport cycle,
as proposed for DA (Borre et al., 2014).
The docking simulations also provide important insights into
the potential functional relevance of the OCA-DAT interaction.
Surprisingly, these results suggest that OCA binds a similar site to
that resolved for ibogaine-bound hSERT (Coleman et al., 2019) in
the occluded state (Figure 6C). Ibogaine is a non-competitive
inhibitor for both DAT and SERT and has been proposed to
stabilize the transporters in the IF conformation (Jacobs et al.,
2007; Bulling et al., 2012). It is important to consider that
compounds that bind to the S1 or S2 site (or at both sites)
would induce an inhibition of substrate transport. However, we
observed that OCA binds in a non-competitive way with respect
to DA (Figure 4). One possibility is that the predominant form of
OCA present in experiments carried a negative-charge and
therefore did not bind the S1 site as modeled for OCA(−) in
the OFo state (Figure 6, panel A). The negatively-charged OCA,
in fact, binds only superficially near the entrance to the EC
vestibule of DAT and could only exert a limited effect on DA
transport. Further studies on the residues involved in the binding
will aid in clarification of this point.
Of note, our model points to a separate site, of equal potential
functional impact, for OCA on DAT; residues R445 and D436
(Figure 6A) which are involved in the formation of salt bridges in
FIGURE 5 | LCA induces a current that parallels the OCA-induced current. (A) Structure of OCA and LCA (B) Representative trace of current recorded with TEVC
(Vh  −60 mV) in oocytes expressing mDAT and perfused with 30 µM DA or 10 µM LCA in ND98 buffer (top). Mean of maximal dopamine transport-associated and
LCA-induced currents (I nA ± SE of 8 oocytes, 3 batches) (bottom). (C)Mean of maximal currents elicited by OCA or LCA in mDAT-expressing oocytes (n  8; p  0.22
by Student’s t-test).
Frontiers in Chemistry | www.frontiersin.org December 2021 | Volume 9 | Article 7539909
Romanazzi et al. Biles Acids Directly Modulate DAT
the IF conformer. In the DAT transport cycle, the binding of DA to
S2 and S1 promotes the closure of the EC gate upon stabilization in
the site S1. It then cooperatively restores the compact association of
the EC vestibule while translocating to the IC vestibule (Cheng and
Bahar, 2015). The IC vestibule opens to the cytoplasm in the IF
conformation only after compaction/closure of the EC-exposed
region (Cheng and Bahar, 2015). The binding of OCAmay stabilize
the IFo state by preventing the re-formation of the IF gating salt
bridges, R60-D436 and R445-E428, that are required for DA
transport (Cheng and Bahar, 2019). Recently, molecular
modeling found that the infantile Parkinsonism-Dystonia
associated substitution, R445C in hDAT, disrupted a
phylogenetically conserved intracellular network of interactions
and promoted a channel-like intermediate of hDAT. These
rearrangements lead to the permeation of Na+ from both the
EC and IC solutions (Aguilar et al., 2021). Interestingly, docking
simulations suggested that OCA could also bind near H444/R445
to stabilize the IF state or act as an anion-lipid (Figure 6A for
OCA(−) in the IFo state). Further experiments will be performed to
confirm the importance of these predicted docking sites for the
interaction of OCA and DAT.
Lastly, the findings reported in Figure 5 confirm that binding to
DAT is not unique toOCA, but takes place also upon application of
LCA, a natural bile acid. This observation is important as this class
of molecules have not been previously reported to interact with
MATs. Thus, BAs in general hold potential as novel
pharmacological tools that could potentially impact important
MAT functions, such as the channel-like activity of DAT.
DATA AVAILABILITY STATEMENT
The datasets presented in this study can be found in online
repositories. The names of the repository/repositories and
accession number(s) can be found in the article.
ETHICS STATEMENT
The animal study was reviewed and approved by the Committee
of the “Organismo Preposto al Benessere degli Animali” of the
University of Insubria (OPBA-permit #02_15) and nationally by
Ministero della Salute (permit nr. 1011/2015).
FIGURE 6 |OCA binding to DAT depends on its protonation state and on DAT conformation. (A)Binding of negatively charged (left) and neutral (right)OCA (cyan)
to hDAT in the OFo (top two panels) and IFo (middle and bottom panels) states. The binding energies to OFo hDAT are −6.1 kcal/mol (OCA(−)) and −9.9 kcal/mol
(OCA(n)); and those to the IFo hDAT are −7.5 kcal/mol (OCA(−)) and −8.5 kcal/mol (OCA(n)). Interacting residues making atom-atom contacts closer than 4 Å with OCA
are shown in panels (A–C). (B) Comparison with the known DA-binding pose. Alignment of the top binding poses of OCA(n) (green sticks), OCA(−) (orange sticks)
(left panel) and the resolved DA (van der Waals (vdW) format) bound dDAT (PDB: 4XP1) (middle panel), and detailed view of DA-binding site and comparison of the
non-overlapping spaces occupied by OCA (multiple binding poses) and DA (right panel). (C) Top 1 binding pose of OCA(n) (vdW format; −10.2 kcal/mol) to hDAT
occluded (OCC) conformer (left panel), the resolved ibogaine-bound to hSERT in the OCC state (PDB:6DZV) (middle panel) and alignment, onto hDAT, of top 10
binding poses of OCA(n) (sticks in different colors; average  −9.1 ± 1.0 kcal/mol) and ibogaine bound to SERT (transparent vDW) (right panel). OCA, DA, and ibogaine
are shown in vdW format in (A–C), with cyan, red, blue and white spheres representing the carbon, oxygen, nitrogen and hydrogen atoms, respectively. (D) Molecular
structures of OCA in two protonation states.
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